Search
for
Sort by
Research 511–540 of 779
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- STAT5 Activation in the Dermal Papilla Is Important for Hair Follicle Growth Phase Induction
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of severe alopecia areata with baricitinib
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Alopecia universalis successfully treated with tofacitinib
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- Efficacy of tofacitinib in pediatric alopecia universalis
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias